Health Products

IPLAN RT DOSE (2015-06-12)

· Published by Health Canada · Official notice

Details

Alert type: Medical Device Recall
Category: Medical Device
Issue: Medical Devices
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameModel or catalog number
8000005931
Manufacturer
Brainlab AG
Kapellenstr. 12
Feldkirchen
85622
GERMANY
A. IPLAN RT DOSE21213G

Introduction

Affected Products

A. IPLAN RT DOSE

Reason

A frameless SRS patient treatment was planned with BrainLab Iplan RT dose 4.1.3. The plan was intended for treatment of intra-cranial metastatic lesions located in 3 different regions/isocenters. The customer prescribed 100% dose to 99% of the volume to all three PTVS (defined as "hard constraints").
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime